Trials / Completed
CompletedNCT01693861
"Cancersensor" Chemotherapy
Molecularly Imprinted Polymer Sensors of Modified Nucleosides for Non-invasive Monitoring of Cancer Therapy : Effect of Chemotherapy on Cancerous Proliferation Based on the Dynamic Excretion of Urinary Nucleosides.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational, non randomized study aimed at measuring the effect of chemotherapy in the urinary concentrations of physiological modified nucleosides in 30 patients with metastatic colorectal cancer.
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2012-09-26
- Last updated
- 2025-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01693861. Inclusion in this directory is not an endorsement.